An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial

An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial

Avian influenza: A vaccine for a deadly emergent strain A vaccine candidate to treat a deadly subtype of avian influenza was shown to induce protective antibodies in initial clinical trials. As of March 2017, avian influenza strain A/H7N9 has killed 497 people since 2013, with 1349 confirmed cases....

Full description

Saved in:
Bibliographic Details
Main Authors: Adam D. DeZure, Emily E. Coates, Zonghui Hu, Galina V. Yamshchikov, Kathryn L. Zephir, Mary E. Enama, Sarah H. Plummer, Ingelise J. Gordon, Florence Kaltovich, Sarah Andrews, Adrian McDermott, Michelle C. Crank, Richard A Koup, Richard M. Schwartz, Robert T. Bailer, Xiangjie Sun, John R. Mascola, Terrence M. Tumpey, Barney S. Graham, Julie E. Ledgerwood
Format: article
Language:EN
Published: Nature Portfolio 2017
Subjects:
Immunologic diseases. Allergy
RC581-607
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Online Access:https://doaj.org/article/e2d2da024d7c4739ac5a7e10fb271246
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/e2d2da024d7c4739ac5a7e10fb271246

Similar Items